The National Institute of General Medical Sciences (NIGMS) has announced five new grant awards as part of the
Rapid Acceleration of Diagnostics for Underserved Populations (RADx-UP) program, a National Institutes of Health (NIH)-wide initiative. The program aims to understand the factors associated with disparities in COVID-19 morbidity and mortality and to lay the foundation to reduce disparities in underserved and vulnerable populations who are disproportionately affected by, have the highest infection rates of, and/or are most at risk for complications or poor outcomes from COVID-19.
The awards, which total more than $5.3 million, went to the
Institutional Development Award (IDeA) programs listed below. For more details about a specific award, search
NIH RePORTER by the project number.
Emergency Competitive Revisions for Community-Engaged COVID-19 Testing Interventions Among Underserved and Vulnerable Populations – RADx-UP Phase II (NOT-OD-21-103):
Administrative Supplements to Address Vaccine Hesitancy and Uptake (NOT-OD-21-101):
These awards align with NIGMS’ mission to help develop the nation’s research capacity through programs such as IDeA. For more information about RADx-UP and other Rapid Acceleration of Diagnostics (RADx) programs, visit the
NIH RADx webpage.
Connect With Us: